| Trial ID: | L1056 |
| Source ID: | NCT02338323
|
| Associated Drug: |
Febuxostat
|
| Title: |
Compare the Renal Protective Effects of Febuxostat and Benzbromarone
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Hyperuricemia|Abnormal Renal Function
|
| Interventions: |
DRUG: Febuxostat|DRUG: Benzbromarone
|
| Outcome Measures: |
Primary: Renal function, Blood test for serum uric acid and creatinine, according to equation to estimate glomerular filtration rate, up to 12th months | Secondary: urine protein, urine test for microprotein markers and 24-hour urine protein quantitation, 3rd months, 6th months, 9th months, 12th months|adverse drug reaction, record all the adverse drug reactions, 1st month, 2nd months, 3rd months, 6th months, 9th months, 12th months
|
| Sponsor/Collaborators: |
Sponsor: Shanghai 10th People's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
160
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-01
|
| Completion Date: |
2018-12
|
| Results First Posted: |
|
| Last Update Posted: |
2019-07-24
|
| Locations: |
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai, Shanghai, 200072, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02338323
|
